Cargando…

Fibrinogen Deficiency with Thrombotic Manifestations

Fibrinogen deficiencies are very rare. Qualitative fibrinogen deficiencies (dysfibrinogenaemia and hypodysfibrinogenemia) are functional disorders that can present with both haemorrhagic symptoms and with thrombotic phenomena as unique and paradoxical manifestation. We present the case of a 77-year-...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamayo-Velasco, Álvaro, Cebeira, María José, Bombín-Canal, Carolina, Acevedo-García, Rosa María, Peñarrubia-Ponce, María Jesús
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SMC Media Srl 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267712/
https://www.ncbi.nlm.nih.gov/pubmed/35821906
http://dx.doi.org/10.12890/2022_003400
_version_ 1784743799868620800
author Tamayo-Velasco, Álvaro
Cebeira, María José
Bombín-Canal, Carolina
Acevedo-García, Rosa María
Peñarrubia-Ponce, María Jesús
author_facet Tamayo-Velasco, Álvaro
Cebeira, María José
Bombín-Canal, Carolina
Acevedo-García, Rosa María
Peñarrubia-Ponce, María Jesús
author_sort Tamayo-Velasco, Álvaro
collection PubMed
description Fibrinogen deficiencies are very rare. Qualitative fibrinogen deficiencies (dysfibrinogenaemia and hypodysfibrinogenemia) are functional disorders that can present with both haemorrhagic symptoms and with thrombotic phenomena as unique and paradoxical manifestation. We present the case of a 77-year-old man being investigated for a partially thrombosed abdominal aortic aneurysm as well as an ischaemic stroke 20 years previously. Basic coagulation tests were normal but extended tests revealed a lengthened thrombin time (TT) combined with a significant drop in fibrinogen concentration measured with the Clauss assay and by nephelometry. After secondary fibrinogen deficiencies were ruled out, a heterozygous variant in the FGG gene was detected by next-generation sequencing, and congenital hypodysfibrinogenemia was diagnosed. Acenocumarol was initiated and no new thrombotic or haemorrhagic events had occurred after a year of follow-up. In almost 25% of cases, thrombotic events may be the only clinical manifestation of functional fibrinogen deficiencies. They are a rare cause of thrombophilia, and are probably underdiagnosed due to normal standard coagulation test results as well as a possible absence of haemorrhagic events. Consequently, a TT test (an initial ‘rule out’ test) should be requested in order to promptly identify these patients. Moreover, discrepancies in derived and Clauss fibrinogen test results should suggest a functional disorder. Finally, new coagulation techniques based on the functional characterization of clot formation, such as ROTEM or thrombin generation assay, could help characterize these entities and suggest new therapeutic approaches. LEARNING POINTS: Functional fibrinogen deficiencies can present with thrombotic manifestations only, and are a rare and probably underdiagnosed cause of thrombophilia. Thrombin time is a highly sensitive test to rule out other conditions as aPTT and PT results may be within normal ranges, especially in functional deficiencies. Discrepancies between derived and Clauss fibrinogen findings, fibrinogen protein measurements and the use of new techniques (ROTEM or thrombin generation) are important for correct approach.
format Online
Article
Text
id pubmed-9267712
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SMC Media Srl
record_format MEDLINE/PubMed
spelling pubmed-92677122022-07-11 Fibrinogen Deficiency with Thrombotic Manifestations Tamayo-Velasco, Álvaro Cebeira, María José Bombín-Canal, Carolina Acevedo-García, Rosa María Peñarrubia-Ponce, María Jesús Eur J Case Rep Intern Med Article Fibrinogen deficiencies are very rare. Qualitative fibrinogen deficiencies (dysfibrinogenaemia and hypodysfibrinogenemia) are functional disorders that can present with both haemorrhagic symptoms and with thrombotic phenomena as unique and paradoxical manifestation. We present the case of a 77-year-old man being investigated for a partially thrombosed abdominal aortic aneurysm as well as an ischaemic stroke 20 years previously. Basic coagulation tests were normal but extended tests revealed a lengthened thrombin time (TT) combined with a significant drop in fibrinogen concentration measured with the Clauss assay and by nephelometry. After secondary fibrinogen deficiencies were ruled out, a heterozygous variant in the FGG gene was detected by next-generation sequencing, and congenital hypodysfibrinogenemia was diagnosed. Acenocumarol was initiated and no new thrombotic or haemorrhagic events had occurred after a year of follow-up. In almost 25% of cases, thrombotic events may be the only clinical manifestation of functional fibrinogen deficiencies. They are a rare cause of thrombophilia, and are probably underdiagnosed due to normal standard coagulation test results as well as a possible absence of haemorrhagic events. Consequently, a TT test (an initial ‘rule out’ test) should be requested in order to promptly identify these patients. Moreover, discrepancies in derived and Clauss fibrinogen test results should suggest a functional disorder. Finally, new coagulation techniques based on the functional characterization of clot formation, such as ROTEM or thrombin generation assay, could help characterize these entities and suggest new therapeutic approaches. LEARNING POINTS: Functional fibrinogen deficiencies can present with thrombotic manifestations only, and are a rare and probably underdiagnosed cause of thrombophilia. Thrombin time is a highly sensitive test to rule out other conditions as aPTT and PT results may be within normal ranges, especially in functional deficiencies. Discrepancies between derived and Clauss fibrinogen findings, fibrinogen protein measurements and the use of new techniques (ROTEM or thrombin generation) are important for correct approach. SMC Media Srl 2022-06-28 /pmc/articles/PMC9267712/ /pubmed/35821906 http://dx.doi.org/10.12890/2022_003400 Text en © EFIM 2022 https://creativecommons.org/licenses/by-nc-nd/4.0/This article is licensed under a Commons Attribution Non-Commercial 4.0 License (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Article
Tamayo-Velasco, Álvaro
Cebeira, María José
Bombín-Canal, Carolina
Acevedo-García, Rosa María
Peñarrubia-Ponce, María Jesús
Fibrinogen Deficiency with Thrombotic Manifestations
title Fibrinogen Deficiency with Thrombotic Manifestations
title_full Fibrinogen Deficiency with Thrombotic Manifestations
title_fullStr Fibrinogen Deficiency with Thrombotic Manifestations
title_full_unstemmed Fibrinogen Deficiency with Thrombotic Manifestations
title_short Fibrinogen Deficiency with Thrombotic Manifestations
title_sort fibrinogen deficiency with thrombotic manifestations
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267712/
https://www.ncbi.nlm.nih.gov/pubmed/35821906
http://dx.doi.org/10.12890/2022_003400
work_keys_str_mv AT tamayovelascoalvaro fibrinogendeficiencywiththromboticmanifestations
AT cebeiramariajose fibrinogendeficiencywiththromboticmanifestations
AT bombincanalcarolina fibrinogendeficiencywiththromboticmanifestations
AT acevedogarciarosamaria fibrinogendeficiencywiththromboticmanifestations
AT penarrubiaponcemariajesus fibrinogendeficiencywiththromboticmanifestations